NL166620C - Werkwijze voor de bereiding van een waterig tetra- cycline-preparaat dat een zuuramide bevat. - Google Patents

Werkwijze voor de bereiding van een waterig tetra- cycline-preparaat dat een zuuramide bevat.

Info

Publication number
NL166620C
NL166620C NL7614470.A NL7614470A NL166620C NL 166620 C NL166620 C NL 166620C NL 7614470 A NL7614470 A NL 7614470A NL 166620 C NL166620 C NL 166620C
Authority
NL
Netherlands
Prior art keywords
preparing
acid amide
preparation containing
aqueous tetra
cycline
Prior art date
Application number
NL7614470.A
Other languages
English (en)
Dutch (nl)
Other versions
NL7614470A (nl
NL166620B (nl
Inventor
William Wellesley Armstrong
Saurabhkumar Jayavantrai Desai
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7614470A publication Critical patent/NL7614470A/xx
Publication of NL166620B publication Critical patent/NL166620B/xx
Application granted granted Critical
Publication of NL166620C publication Critical patent/NL166620C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
NL7614470.A 1976-01-02 1976-12-28 Werkwijze voor de bereiding van een waterig tetra- cycline-preparaat dat een zuuramide bevat. NL166620C (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/646,295 US4018889A (en) 1976-01-02 1976-01-02 Oxytetracycline compositions
CA268,177A CA1075603A (en) 1976-01-02 1976-12-17 Stable solutions of doxycycline in aqueous 2-pyrrolidone
KR7700012A KR810000900B1 (ko) 1976-01-02 1977-01-06 항생물질 조성제의 안정화 방법

Publications (3)

Publication Number Publication Date
NL7614470A NL7614470A (nl) 1977-07-05
NL166620B NL166620B (nl) 1981-04-15
NL166620C true NL166620C (nl) 1981-09-15

Family

ID=27164830

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7614470.A NL166620C (nl) 1976-01-02 1976-12-28 Werkwijze voor de bereiding van een waterig tetra- cycline-preparaat dat een zuuramide bevat.

Country Status (29)

Country Link
US (3) US4018889A (instruction)
JP (1) JPS5290616A (instruction)
KR (1) KR810000900B1 (instruction)
AR (1) AR209242A1 (instruction)
AT (1) AT345977B (instruction)
BE (1) BE849885A (instruction)
BG (1) BG36493A3 (instruction)
CA (2) CA1075603A (instruction)
CH (1) CH616080A5 (instruction)
CS (1) CS205030B2 (instruction)
DD (1) DD129997A5 (instruction)
DE (1) DE2659152C2 (instruction)
DK (1) DK145753C (instruction)
EG (1) EG12291A (instruction)
FI (1) FI56116C (instruction)
FR (1) FR2336937A1 (instruction)
GB (1) GB1520197A (instruction)
GR (1) GR65305B (instruction)
HK (1) HK30181A (instruction)
IE (1) IE44767B1 (instruction)
IN (1) IN145845B (instruction)
KE (1) KE3166A (instruction)
LU (1) LU76493A1 (instruction)
NL (1) NL166620C (instruction)
OA (1) OA05524A (instruction)
PT (1) PT66017B (instruction)
SE (1) SE435997B (instruction)
SU (1) SU1309901A3 (instruction)
ZA (1) ZA767689B (instruction)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4126680A (en) * 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
DE2963584D1 (en) * 1978-08-01 1982-10-21 Ciba Geigy Ag Stable, liquid pharmaceutical formulation, its preparation and use
DE2965917D1 (en) * 1978-12-08 1983-08-25 Beecham Group Plc A process for the preparation of a solid sodium amoxycillin and aqueous solutions thereof
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
ATE4166T1 (de) * 1979-07-02 1983-08-15 Pfizer Inc. Langwirkende injizierbare sulfonamidzusammensetzungen.
EP0022342B1 (en) * 1979-07-05 1983-06-15 Pfizer Inc. Sulfonamide solutions
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
CA1163197A (en) * 1980-04-10 1984-03-06 Herman Horn Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
US4374826A (en) * 1980-07-21 1983-02-22 Pfizer Inc. Sulfonamide compositions
NL178941C (nl) * 1982-06-15 1986-06-16 Aesculaap Bv Werkwijze voor de bereiding van een waterig oxytetracyclinepreparaat.
US4769232A (en) * 1984-03-22 1988-09-06 Pfizer Inc. Parenteral formulations of indolmycin
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
FR2608044B1 (fr) * 1986-12-10 1992-09-11 Sogeval Composition antibiotique aqueuse a usage veterinaire
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
EP1666453A1 (en) * 1999-09-14 2006-06-07 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
AU2001228454A1 (en) * 2000-01-13 2001-07-24 Merck Patent G.M.B.H Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
WO2001052858A1 (en) 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
AU2001251157A1 (en) * 2000-03-31 2001-10-15 Paratek Pharmaceuticals, Inc 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
CA2409063A1 (en) 2000-05-15 2001-11-22 Mark L. Nelson 7-substituted fused ring tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
EP1301465A2 (en) 2000-07-07 2003-04-16 Trustees Of Tufts College 13-substituted methacycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
CA2415718C (en) * 2000-07-07 2012-08-28 Trustees Of Tufts College 7-substituted tetracycline compounds
WO2002004404A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
HU229577B1 (en) 2000-07-07 2014-02-28 Tufts College 9-substituted minocycline derivatives
RU2178698C1 (ru) * 2000-11-28 2002-01-27 Закрытое Акционерное Общество "Нита-Фарм" Способ получения композиции магниевого комплекса окситетрациклина пролонгированного действия
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
EP1241160A1 (en) * 2001-03-13 2002-09-18 Glaxo Group Limited Tetracycline derivatives and their use as antibiotic agents
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
HUP0402047A3 (en) 2001-03-13 2012-10-29 Paratek Pharmaceuticals 7,9-substituted tetracycline compounds, their use and pharmaceutical compositions containing them
WO2002072022A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
ES2338994T3 (es) 2001-04-24 2010-05-14 Paratek Pharmaceuticals, Inc. Compuestos de tetraciclina sustituida para el tratamiento de la malaria.
US20030181371A1 (en) * 2001-12-28 2003-09-25 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collajolie
WO2003057169A2 (en) 2002-01-08 2003-07-17 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA200802365A1 (ru) 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
CN101712632A (zh) 2002-03-21 2010-05-26 帕拉特克药品公司 取代的四环素化合物
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
CA2492273C (en) 2002-07-12 2013-02-05 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
EP2277504A1 (en) 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
AU2003300379A1 (en) * 2002-12-27 2004-07-29 Angiotech Pharmaceuticals, Inc. Compositions and methods of using collagen and MMPI
AU2004259659B2 (en) 2003-07-09 2011-11-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20050137174A1 (en) 2003-07-09 2005-06-23 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
WO2005011707A1 (en) * 2003-07-25 2005-02-10 Warner Chilcott Company, Inc. A doxycycline metal complex in a solid dosage form
CA2553510C (en) * 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2269978A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2006047671A2 (en) * 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
CA2595481C (en) * 2005-01-21 2014-05-13 Warner Chilcott Company, Inc. A tetracycline metal complex in a solid dosage form
EP1848685A1 (en) 2005-02-04 2007-10-31 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
AU2007208214B2 (en) 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
WO2007120913A2 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
EP2857386B1 (en) * 2006-04-24 2017-02-22 Teva Pharmaceutical Industries Ltd Tigecycline crystalline forms and processes for preparation thereof
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
JP2009543544A (ja) * 2006-05-15 2009-12-10 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を調節する方法
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
EP3812372A3 (en) 2006-12-21 2021-06-30 Paratek Pharmaceuticals, Inc. 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases
PL2120963T3 (pl) 2006-12-21 2019-05-31 Paratek Pharm Innc Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
AU2008239606A1 (en) * 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
US9434680B2 (en) 2007-04-27 2016-09-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
US9522872B2 (en) 2007-07-06 2016-12-20 Paratek Pharmaceuticals, Inc. Methods for synthesizing substituted tetracycline compounds
KR20100126469A (ko) 2008-03-05 2010-12-01 파라테크 파마슈티컬스, 인크. 미노사이클린 화합물 및 이들의 사용 방법
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US20100022483A1 (en) * 2008-04-14 2010-01-28 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
TW202021946A (zh) 2008-05-19 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
AP2011005631A0 (en) * 2008-09-19 2011-04-30 Paratek Pharmaceuticals Ind Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment.
AU2010233089B2 (en) 2009-04-10 2016-05-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (MMP-1)
MX347919B (es) 2010-05-12 2017-05-17 Rempex Pharmaceuticals Inc * Composiciones de tetraciclina.
PL2707003T3 (pl) 2011-05-12 2019-11-29 Paratek Pharm Innc Krystaliczne sole amidu kwasu (4s,4as,5ar,12as)-4-dimetyloamino-3,10,12,12a-tetrahydroksy-7-[(metoksy(metylo)amino)metylo]-1,11-diokso- 1,4,4a,5,5a,6,11,12a-oktahydronaftaceno- 2-karboksylowego i sposoby ich stosowania
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2015021387A2 (en) * 2013-08-09 2015-02-12 Britt George N Formulations for control and prevention of periodontal and perimplant diseases and other diseases and conditions of the mouth, and supra and sub-gingival delivery methods and systems for such formulations
CN103536530A (zh) * 2013-10-30 2014-01-29 王玉万 盐酸多西环素长效注射剂及制备方法
CN107708665B (zh) 2015-03-23 2022-07-22 贝尔生物制药有限公司 用于皮肤病学用途的药用四环素组合物
CN104721133B (zh) * 2015-04-14 2018-05-18 四川美嘉龙生物科技有限公司 一种土霉素制剂及制备方法
AU2017353588B2 (en) 2016-11-01 2022-07-14 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating Community-Acquired Bacterial Pneumonia (CABP)
US20200222432A1 (en) 2017-07-21 2020-07-16 Almirall, Llc. Treatment of non-inflammatory lesions
WO2019106036A1 (en) 2017-11-28 2019-06-06 C-Lecta Gmbh Method for producing trehalose employing a trehalose phosphorylase variant
US11426351B2 (en) 2019-12-26 2022-08-30 Sunstar Inc. Process for producing a pharmaceutical composition containing micro particles

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB805026A (en) * 1956-03-02 1958-11-26 Konink Nl Gisten Spiritusfabri Process for enhancing the solubility of medicines in water
GB802111A (en) * 1956-09-25 1958-10-01 Irwin Irville Lubowe Improved non-toxic pesticidal compositions
US2990331A (en) * 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
DE1091287B (de) * 1957-04-09 1960-10-20 Byk Gulden Lomberg Chem Fab Verfahren zur Herstellung stabiler, waessriger Loesungen von Tyrothricin und Subtilin
US2980584A (en) * 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2987437A (en) * 1958-03-06 1961-06-06 Gen Aniline & Film Corp Nematocidal composition
US3062717A (en) * 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3957972A (en) * 1966-05-31 1976-05-18 Koninklijke Nederlandsche Gist-En Spiritusfabriek N.V. Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
NL6607516A (instruction) * 1966-05-31 1967-12-01
DE1767891C3 (de) * 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) * 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
GB1508601A (en) * 1974-01-19 1978-04-26 Norbrook Labor Ltd Oxytetracycline solution
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
US3932653A (en) * 1974-12-19 1976-01-13 Nelson Research & Development Co. Composition and method for topical administration of griseofulvin
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
GB1538903A (en) 1975-04-11 1979-01-24 Nelson Res & Dev Carrier for a topically applied physiologically active agent or cosmetic agent

Also Published As

Publication number Publication date
ATA971776A (de) 1978-02-15
IE44767B1 (en) 1982-03-24
FI56116B (fi) 1979-08-31
CH616080A5 (instruction) 1980-03-14
US4086332A (en) 1978-04-25
CA1072012A (en) 1980-02-19
AT345977B (de) 1978-10-10
NL7614470A (nl) 1977-07-05
JPS5290616A (en) 1977-07-30
PT66017B (en) 1978-06-19
BG36493A3 (en) 1984-11-15
IE44767L (en) 1977-07-02
DE2659152A1 (de) 1977-07-14
JPS565368B2 (instruction) 1981-02-04
AR209242A1 (es) 1977-03-31
DD129997A5 (de) 1978-03-01
PT66017A (en) 1977-01-01
KE3166A (en) 1981-11-06
HK30181A (en) 1981-07-10
BE849885A (fr) 1977-06-28
FI763716A7 (instruction) 1977-07-03
DK584676A (da) 1977-07-03
FI56116C (fi) 1979-12-10
IN145845B (instruction) 1979-01-06
DK145753C (da) 1983-08-08
CS205030B2 (en) 1981-04-30
DE2659152C2 (de) 1984-04-05
ZA767689B (en) 1977-12-28
US4018889A (en) 1977-04-19
FR2336937B1 (instruction) 1980-06-27
NL166620B (nl) 1981-04-15
EG12291A (en) 1978-09-30
US4081528A (en) 1978-03-28
SU1309901A3 (ru) 1987-05-07
GR65305B (en) 1980-08-01
DK145753B (da) 1983-02-21
OA05524A (fr) 1981-04-30
KR810000900B1 (ko) 1981-08-19
SE7613959L (sv) 1977-07-03
CA1075603A (en) 1980-04-15
SE435997B (sv) 1984-11-05
FR2336937A1 (fr) 1977-07-29
LU76493A1 (instruction) 1977-07-05
GB1520197A (en) 1978-08-02
AU2057176A (en) 1978-09-28

Similar Documents

Publication Publication Date Title
NL166620C (nl) Werkwijze voor de bereiding van een waterig tetra- cycline-preparaat dat een zuuramide bevat.
NL7708633A (nl) Werkwijze voor de bereiding van d(-)-3-hydroxy- boterzuur.
NL187102C (nl) Werkwijze voor de bereiding van een farmaceutisch preparaat dat een 2-fenylimidazolidinon bevat, gevormd preparaat verkregen met deze werkwijze, alsmede werkwijze voor de bereiding van imidazolidinonen.
NL7604963A (nl) Werkwijze voor de bereiding van koolzuur- houdend snoep.
NL169030C (nl) Werkwijze voor het bereiden van een aminozuurpreparaat, geschikt voor leverpatienten.
NL7605540A (nl) Werkwijze voor de bereiding van melkzuur.
NL7701865A (nl) Werkwijze voor de bereiding van tereftaalzuur.
NL182217C (nl) Werkwijze voor de bereiding van 2-oxo-3-arylpropionzuur.
NL175435C (nl) Werkwijze voor de bereiding van optisch aktieve aminozuurverbindingen.
NL7607368A (nl) Werkwijze voor de bereiding van een aldohexu- ronzuur bevattende zoetstof.
NL7507927A (nl) Werkwijze voor de bereiding van fenylcarbaminezuur- derivaten.
NL182954C (nl) Werkwijze voor het bereiden van alfa-aminozuuramide.
NL7700446A (nl) Werkwijze voor de bereiding van zouten van 3.3-dimethyl-2-oxoboterzuur.
NL7707308A (nl) Werkwijze ter bereiding van 2-broom-6-fluor- -n-2-imidazolidinylideenbenzamide en de zuur- additiezouten daarvan en van preparaten, die deze verbindingen bevatten.
NL186695C (nl) Werkwijze voor het bereiden van nicotinezuuramide.
NL7700539A (nl) Werkwijze ter bereiding van zuuramiden.
NL7708091A (nl) Werkwijze voor de bereiding van fenoxy-fenoxy- -alkaancarbonzuurderivaten.
NL162613C (nl) Werkwijze voor de bereiding van vanadium-arme alkalime- taalfosfaatoplossingen.
NL7604330A (nl) Werkwijze voor de bereiding van 8-azaprostaan- zuurderivaten.
NL7509078A (nl) Werkwijze voor de bereiding van prostaanzuur- derivaten.
NL7605837A (nl) Werkwijze voor de bereiding van thenoylazijn- zuurderivaten.
NL7610166A (nl) Werkwijze voor de bereiding van zure microbi- ciden.
NL171821C (nl) Werkwijze voor de bereiding van 6-aminopenicillaanzuur.
NL7701695A (nl) Werkwijze voor de bereiding van 2.2-dimethyl- -3-(2'.2'-dichloorvinyl) cyclopropaan-1-carbon- zuur.
NL7700268A (nl) Werkwijze voor de bereiding van 6-aminocapron- zuuramide.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 961228